{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:54:45Z","timestamp":1780451685249,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.gassur.2024.07.015","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T14:45:27Z","timestamp":1722005127000},"page":"1605-1612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluating complete response rates and predictors in total neoadjuvant therapy for rectal cancer"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2193-9984","authenticated-orcid":false,"given":"Kamil","family":"Erozkan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doua","family":"Elamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed Enes","family":"Tasci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Liska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alipouriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Schabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Lavryk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brogan","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smitha","family":"Krishnamurthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob A.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei S.","family":"Purysko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7725-3522","authenticated-orcid":false,"given":"Emre","family":"Gorgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.gassur.2024.07.015_bib1","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/annonc\/mdx351","article-title":"Late toxicities and clinical outcome at 5 years of the Accord 12\/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer","volume":"28","author":"Azria","year":"2017","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.gassur.2024.07.015_bib2","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gassur.2024.07.015_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1470-2045(14)71199-4","article-title":"Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data","volume":"16","author":"Breugom","year":"2015","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.gassur.2024.07.015_bib4","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/annonc\/mdu560","article-title":"Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial","volume":"26","author":"Breugom","year":"2015","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.gassur.2024.07.015_bib5","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/annonc\/mdu147","article-title":"Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control","volume":"25","author":"Glynne-Jones","year":"2014","journal-title":"Chron Ann Oncol"},{"key":"10.1016\/j.gassur.2024.07.015_bib6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.6004\/jnccn.2022.0051","article-title":"Rectal cancer. Version 2.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"20","author":"Benson","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"10.1016\/j.gassur.2024.07.015_bib7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with folfirinox and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2024.07.015_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2024.07.015_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0071","article-title":"Adoption of total neoadjuvant therapy for locally advanced rectal cancer","volume":"4","author":"Cercek","year":"2018","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.gassur.2024.07.015_bib10","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S1470-2045(15)00004-2","article-title":"Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial","volume":"16","author":"Garcia-Aguilar","year":"2015","journal-title":"Lancet Oncol"},{"issue":"23","key":"10.1016\/j.gassur.2024.07.015_bib11","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2024.07.015_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clcc.2021.11.001","article-title":"The potential for overtreatment with total neoadjuvant therapy (TNT): consider one local therapy instead","volume":"21","author":"Anker","year":"2022","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.gassur.2024.07.015_bib13","article-title":"Active surveillance in long period of total neoadjuvant therapy in rectal cancer: early prediction of poor regression response","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.gassur.2024.07.015_bib14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/DCR.0000000000002245","article-title":"Rectal cancer: clinical and molecular predictors of a complete response to total neoadjuvant therapy","volume":"66","author":"Chapman","year":"2023","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.gassur.2024.07.015_bib15","doi-asserted-by":"crossref","unstructured":"Yilmaz S, Tursun N, Conces M, Elamin D, Ozgur I, Maspero M, et al. What predicts complete response to TNT in locally advanced rectal cancer? In: Editor eds. Book what predicts complete response to TNT in locally advanced rectal cancer? Chicago, IL; 2023, S-1479-S-1480.","DOI":"10.1016\/S0016-5085(23)04475-X"},{"issue":"4","key":"10.1016\/j.gassur.2024.07.015_bib16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"10.1016\/j.gassur.2024.07.015_bib17","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/DCR.0b013e3181f42b89","article-title":"Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization","volume":"53","author":"Habr-Gama","year":"2010","journal-title":"Dis Colon Rectum"},{"issue":"28","key":"10.1016\/j.gassur.2024.07.015_bib18","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1200\/JCO.2011.34.9068","article-title":"Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: mercury experience","volume":"29","author":"Patel","year":"2011","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.gassur.2024.07.015_bib19","doi-asserted-by":"crossref","first-page":"dju248","DOI":"10.1093\/jnci\/dju248","article-title":"Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment","volume":"106","author":"Trakarnsanga","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.gassur.2024.07.015_bib20","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/DCR.0000000000002122","article-title":"Organ preservation in patients with rectal cancer treated with total neoadjuvant therapy","volume":"64","author":"Jimenez-Rodriguez","year":"2021","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"10.1016\/j.gassur.2024.07.015_bib21","first-page":"258","article-title":"[Total neoadjuvant therapy followed by watch and wait approach or organ preservation for MRI stratified low-risk rectal cancer: early result from a prospective, single arm trial]","volume":"23","author":"Wang","year":"2020","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"issue":"12","key":"10.1016\/j.gassur.2024.07.015_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.30097","article-title":"Total neoadjuvant therapy vs standard therapy in locally advanced rectal cancer: a systematic review and meta-analysis","volume":"3","author":"Kasi","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.gassur.2024.07.015_bib23","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/DCR.0000000000001207","article-title":"Consolidation mFOLFOX6 chemotherapy after chemoradiotherapy improves survival in patients with locally advanced rectal cancer: final results of a multicenter Phase II trial","volume":"61","author":"Marco","year":"2018","journal-title":"Dis Colon Rectum"},{"issue":"7","key":"10.1016\/j.gassur.2024.07.015_bib24","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/annonc\/mdl085","article-title":"Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation","volume":"17","author":"Calvo","year":"2006","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.gassur.2024.07.015_bib25","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/bjs\/znad177","article-title":"Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials","volume":"110","author":"Donnelly","year":"2023","journal-title":"Br J Surg"},{"issue":"9","key":"10.1016\/j.gassur.2024.07.015_bib26","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.3390\/cancers15092567","article-title":"Selecting a TNT schedule in locally advanced rectal cancer: can we predict who actually benefits?","volume":"15","author":"Aschele","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.gassur.2024.07.015_bib27","first-page":"379","article-title":"Prediction of short-term results after laparoscopic right hemicolectomy. Is sarcopenia superior to other methods?","volume":"92","author":"Er\u00f6zkan","year":"2023","journal-title":"Cir Cir"},{"issue":"1","key":"10.1016\/j.gassur.2024.07.015_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jso.27251","article-title":"Can sarcopenia predict complete response after total neoadjuvant therapy in advanced rectal cancer? A multicentre observational cohort study","volume":"128","author":"Bedrikovetski","year":"2023","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2024.07.015_bib29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1186\/s12885-023-10984-2","article-title":"A multi-centre randomized controlled trial investigating Consolidation Chemotherapy with and without oxaliplatin in distal rectal cancer and Watch & Wait","volume":"23","author":"Habr-Gama","year":"2023","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.gassur.2024.07.015_bib30","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1245\/s10434-023-13225-9","article-title":"MRI assessment of extramural venous invasion before and after total neoadjuvant therapy for locally advanced rectal cancer and its association with disease-free and overall survival","volume":"30","author":"Thompson","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2024.07.015_bib31","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/jso.26818","article-title":"MRI-detected extramural vascular invasion (mrEMVI) as the best predictive factor to identify candidates to total neoadjuvant therapy in locally advanced rectal cancer","volume":"125","author":"Massucco","year":"2022","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.gassur.2024.07.015_bib32","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1186\/s12885-022-09947-w","article-title":"Neoadjuvant folfoxiri prior to chemoradiotherapy for high-risk (\u201cugly\u201d) locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)","volume":"22","author":"van den Berg","year":"2022","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.gassur.2024.07.015_bib33","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1007\/s00261-023-03961-7","article-title":"Predicting response to chemoradiotherapy in rectal cancer via visual morphologic assessment and staging on baseline MRI: a multicenter and multireader study","volume":"48","author":"El Khababi","year":"2023","journal-title":"Abdom Radiol"},{"issue":"15","key":"10.1016\/j.gassur.2024.07.015_bib34","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1200\/JCO.21.01667","article-title":"Multicenter, randomized, Phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR)","volume":"40","author":"Jin","year":"2022","journal-title":"J Clin Oncol"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X24005444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X24005444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T11:49:18Z","timestamp":1727869758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X24005444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1091255X24005444"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2024.07.015","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating complete response rates and predictors in total neoadjuvant therapy for rectal cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2024.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}